Point72 Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.7M | Sell |
201,396
-99,239
| -33% | -$32.4M | 0.13% | 190 |
|
|
2025
Q1 | $81.2M | Buy |
+300,635
| New | +$81.2M | 0.19% | 117 |
|
|
2024
Q2 | – | Sell |
-206,255
| Closed | -$30.8M | – | 1175 |
|
|
2024
Q1 | $30.8M | Buy |
206,255
+120,265
| +140% | +$18M | 0.07% | 293 |
|
|
2023
Q4 | $16.5M | Buy |
+85,990
| New | +$16.5M | 0.04% | 433 |
|
|
2022
Q4 | – | Sell |
-14,570
| Closed | -$2.92M | – | 1093 |
|
|
2022
Q3 | $2.92M | Sell |
14,570
-318,630
| -96% | -$63.8M | 0.01% | 710 |
|
|
2022
Q2 | $48.6M | Buy |
+333,200
| New | +$48.6M | 0.21% | 125 |
|
|
2021
Q4 | – | Sell |
-99,512
| Closed | -$18.8M | – | 1006 |
|
|
2021
Q3 | $18.8M | Sell |
99,512
-20,177
| -17% | -$3.81M | 0.08% | 307 |
|
|
2021
Q2 | $20.3M | Sell |
119,689
-320,248
| -73% | -$54.3M | 0.09% | 270 |
|
|
2021
Q1 | $62.1M | Sell |
439,937
-41,963
| -9% | -$5.92M | 0.29% | 77 |
|
|
2020
Q4 | $62.6M | Buy |
+481,900
| New | +$62.6M | 0.31% | 67 |
|
|
2019
Q3 | – | Sell |
-398,928
| Closed | -$28.9M | – | 1048 |
|
|
2019
Q2 | $28.9M | Buy |
+398,928
| New | +$28.9M | 0.15% | 155 |
|
|
2018
Q4 | – | Sell |
-885,312
| Closed | -$77.5M | – | 833 |
|
|
2018
Q3 | $77.5M | Sell |
885,312
-471,096
| -35% | -$41.2M | 0.32% | 64 |
|
|
2018
Q2 | $134M | Buy |
1,356,408
+448,362
| +49% | +$44.2M | 0.53% | 31 |
|
|
2018
Q1 | $108M | Buy |
908,046
+819,160
| +922% | +$97.6M | 0.45% | 37 |
|
|
2017
Q4 | $11.3M | Buy |
88,886
+3,886
| +5% | +$494K | 0.05% | 346 |
|
|
2017
Q3 | $9.99M | Buy |
85,000
+35,000
| +70% | +$4.11M | 0.04% | 323 |
|
|
2017
Q2 | $3.99M | Buy |
+50,000
| New | +$3.99M | 0.02% | 465 |
|
|
2014
Q4 | – | Sell |
-12,100
| Closed | -$945K | – | 609 |
|
|
2014
Q3 | $945K | Buy |
+12,100
| New | +$945K | 0.01% | 518 |
|